JARDIANCE MET 12.5/500 MG

1. All Details: Specifications
Dosage Form: Film-coated tablets.
Storage Conditions: Store in a safe place out of the reach of children. Do not store above 30°C.
Batch Number (Batch No.): F64838
Manufacturing Date (Mfg Date): 12/2023
Expiry Date (Expiry Date): 11/2026
Import Licence Number: IL/FF-000435 RC/FF-002092
Maximum Retail Price (M.R.P.): ₹ 416.00 (indicated as “For 10 tablets M.R.P. inclusive of all taxes ₹ 416.00” on the foil and corroborated by the white sticker overlay).
Retail Sticker Identifiers: SS007, 11/26, Jardiance Met 12.5 mg, 9990102646767, F64838.
2. General
Brand: jardiance® met
Generic Name: Fixed Dose Combination of Empagliflozin and Metformin Hydrochloride Tablets
Strength Variant: 12.5 mg/500 mg
Quantity: 10 Tablets per blister pack (indicated by “For 10 tablets”).
Type: Allopathic Pharmaceutical / Prescription Drug (indicated by the “Rx” symbol and the red statutory prescription caution warning boxes).
Form Factor: Blister strip containing solid oral film-coated tablets.
Maximum Shelf Life: 2 years and 11 months (from December 2023 to November 2026).
Food Preference / FSSAI: Not Applicable. This is a targeted allopathic prescription medication for chronic glycemic management, not a commercial food product or dietary supplement. It is governed strictly under national drug control frameworks instead of the FSSAI food authority, and it does not feature vegetarian or non-vegetarian markings.
3. Product Details: Ingredients
Composition: Each film-coated tablet contains:
Empagliflozin: 12.5 mg
Metformin Hydrochloride I.P.: 500 mg
Excipients: q.s. (Quantity Sufficient)
Colours used: Titanium dioxide I.P., Iron oxide black, Iron oxide red
Route: For oral administration only.
4. Directions: How to Use
Dosage: As directed by physician.
Statutory Warning Label (Schedule H / Schedule G Drug Caution):
The blister features standard red caution boxes restricting retail sale without a valid prescription from a Registered Medical Practitioner.
5. Description
Therapeutic Application: Jardiance® Met is an oral anti-diabetic fixed-dose combination medication used under strict medical guidance to manage Type 2 diabetes mellitus. It combines two distinct mechanisms of action: Empagliflozin, an SGLT2 (sodium-glucose co-transporter 2) inhibitor that works by removing excess sugar from the body through urine, and Metformin Hydrochloride, a biguanide that lowers glucose production in the liver and improves the body’s sensitivity to insulin. Together, they provide synergistic glycemic control for patients needing combined therapy.
Visual Presentation: The product is packed in a sturdy, textured silver aluminum blister foil designed to protect the tablets from moisture and environmental degradation. The foil features a clean layout with dark green text for the brand variant, standard black print for formulation details, dual red caution strips, a corporate Boehringer Ingelheim logo, and a retail barcode sticker overlay tracking inventory economics.
6. Manufacturer Information
Manufactured by: Boehringer Ingelheim Ellas A.E.
Factory Address: 5th km Paiania-Markopoulo, Koropi Attiki, 19400, Greece.
7. Marketed By
Imported and Marketed in India by: Boehringer Ingelheim India Private Limited.